192 related articles for article (PubMed ID: 25274609)
1. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 6: effects of varying pancreatin and calcium levels.
Sassene P; Kleberg K; Williams HD; Bakala-N'Goma JC; Carrière F; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Porter CJ; Pouton CW; Müllertz A
AAPS J; 2014 Nov; 16(6):1344-57. PubMed ID: 25274609
[TBL] [Abstract][Full Text] [Related]
2. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.
Williams HD; Anby MU; Sassene P; Kleberg K; Bakala-N'Goma JC; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Carrière F; Müllertz A; Pouton CW; Porter CJ
Mol Pharm; 2012 Nov; 9(11):3286-300. PubMed ID: 23030411
[TBL] [Abstract][Full Text] [Related]
3. Toward the establishment of standardized in vitro tests for lipid-based formulations. 5. Lipolysis of representative formulations by gastric lipase.
Bakala-N'Goma JC; Williams HD; Sassene PJ; Kleberg K; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Müllertz A; Pouton CW; Porter CJ; Carrière F
Pharm Res; 2015 Apr; 32(4):1279-87. PubMed ID: 25288015
[TBL] [Abstract][Full Text] [Related]
4. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
Keemink J; Mårtensson E; Bergström CAS
Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
[TBL] [Abstract][Full Text] [Related]
5. A simplified method to screen for in-vivo performance of oral lipid formulations.
Kilic M; Dressman J
J Pharm Pharmacol; 2014 May; 66(5):615-23. PubMed ID: 24313318
[TBL] [Abstract][Full Text] [Related]
6. Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.
Mosgaard MD; Sassene P; Mu H; Rades T; Müllertz A
Eur J Pharm Biopharm; 2015 Aug; 94():493-500. PubMed ID: 26159837
[TBL] [Abstract][Full Text] [Related]
7. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
Heider M; Hause G; Mäder K
Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
[TBL] [Abstract][Full Text] [Related]
8. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
[TBL] [Abstract][Full Text] [Related]
9. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.
Devraj R; Williams HD; Warren DB; Mohsin K; Porter CJ; Pouton CW
Eur J Pharm Sci; 2013 Jul; 49(4):748-60. PubMed ID: 23684915
[TBL] [Abstract][Full Text] [Related]
10. Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations.
Hedge OJ; Bergström CAS
Pharm Res; 2020 May; 37(6):99. PubMed ID: 32435855
[TBL] [Abstract][Full Text] [Related]
11. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
[TBL] [Abstract][Full Text] [Related]
12. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs.
Cuiné JF; Charman WN; Pouton CW; Edwards GA; Porter CJ
Pharm Res; 2007 Apr; 24(4):748-57. PubMed ID: 17372700
[TBL] [Abstract][Full Text] [Related]
13. In vitro digestion testing of lipid-based delivery systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products.
Devraj R; Williams HD; Warren DB; Mullertz A; Porter CJ; Pouton CW
Int J Pharm; 2013 Jan; 441(1-2):323-33. PubMed ID: 23178598
[TBL] [Abstract][Full Text] [Related]
14. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
[TBL] [Abstract][Full Text] [Related]
15. Novel Biphasic Lipolysis Method To Predict
O'Dwyer PJ; Box KJ; Koehl NJ; Bennett-Lenane H; Reppas C; Holm R; Kuentz M; Griffin BT
Mol Pharm; 2020 Sep; 17(9):3342-3352. PubMed ID: 32787274
[TBL] [Abstract][Full Text] [Related]
16. Immobilised lipase for in vitro lipolysis experiments.
Phan S; Salentinig S; Hawley A; Boyd BJ
J Pharm Sci; 2015 Apr; 104(4):1311-8. PubMed ID: 25630824
[TBL] [Abstract][Full Text] [Related]
17. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
Feeney OM; Williams HD; Pouton CW; Porter CJ
J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
[TBL] [Abstract][Full Text] [Related]
18. A dynamic in vitro lipolysis model. II: Evaluation of the model.
Zangenberg NH; Müllertz A; Kristensen HG; Hovgaard L
Eur J Pharm Sci; 2001 Oct; 14(3):237-44. PubMed ID: 11576829
[TBL] [Abstract][Full Text] [Related]
19. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.
Williams HD; Sassene P; Kleberg K; Calderone M; Igonin A; Jule E; Vertommen J; Blundell R; Benameur H; Müllertz A; Pouton CW; Porter CJ;
Pharm Res; 2013 Dec; 30(12):3059-76. PubMed ID: 23661145
[TBL] [Abstract][Full Text] [Related]
20. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations.
Williams HD; Sassene P; Kleberg K; Bakala-N'Goma JC; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Carrière F; Müllertz A; Porter CJ; Pouton CW
J Pharm Sci; 2012 Sep; 101(9):3360-80. PubMed ID: 22644939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
